![]() |
市场调查报告书
商品编码
1754110
血管封闭装置市场报告(按产品(发电机、仪器、配件)、应用(一般外科、腹腔镜手术)、最终用户(医院和专科诊所、门诊手术中心)和地区)2025 年至 2033 年Vessel Sealing Devices Market Report by Product (Generators, Instruments, Accessories), Application (General Surgery, Laparoscopic Surgery), End User (Hospitals and Specialty Clinics, Ambulatory Surgical Centers), and Region 2025-2033 |
2024年,全球血管封闭设备市场规模达20亿美元。展望未来, IMARC Group预计到2033年,该市场规模将达到35亿美元,2025-2033年期间的复合年增长率(CAGR)为5.77%。慢性病盛行率的上升、手术器械(尤其是血管封闭设备)技术的进步,以及人们对微创手术日益增长的偏好,共同推动着该市场的发展。
慢性病盛行率上升
癌症、心血管疾病和肥胖等慢性疾病的发生率不断上升,是血管封闭装置市场成长的主要驱动力。由于这些疾病通常需要外科手术治疗,因此对能够提高手术效率和安全性的先进外科设备的需求也在不断增长。根据美国疾病管制与预防中心的数据,美国约有1.29亿人至少患有一种主要慢性疾病,包括心臟病、癌症、糖尿病、肥胖和高血压。此外,美国十大主要死因中有五种与可预防和可治疗的慢性疾病密切相关。血管封闭装置在涉及大量组织操作和止血的手术中尤其重要,因为它们能够持续封闭血管和组织束,减少术中失血和术后併发症。全球慢性疾病负担的加重,加上人口老化,加剧了对外科治疗的需求,从而推动了对有效血管封闭解决方案的需求。
微创手术的采用率不断提高
创造良好血管封闭装置市场前景的另一个关键因素是向微创手术 (MIS) 程序的过渡。根据美国国家医学图书馆的数据,2017 年,共分析了 980 万例住院主要手术室程序,其中 11.1% 为 MIS,2.5% 为机器人辅助,而 2018 年为 960 万例住院手术室程序(11.2% 为 MIS,2.9% 为机器人辅助)。腹腔镜和机器人手术等微创手术与传统开放性手术相比具有多种优势,包括术后疼痛更少、住院时间更短、恢復时间更快以及併发症发生率更低。血管封闭装置对于 MIS 程序至关重要,因为它们能够在有限的手术范围内实现精确和成功的止血。微创手术在患者和医疗保健提供者中的普及导致对复杂血管封闭技术的需求增加。
医疗支出不断上涨
全球医疗支出的增加和医疗基础设施的持续发展是血管封闭设备市场的主要驱动力。根据医疗保险和医疗补助服务中心的数据,美国医疗保健支出成长 4.1%,到 2022 年将达到 4.5 兆美元,高于 2021 年 3.2% 的增幅。此外,2022 年,参保人口比例达到 92%(创历史新高)。私人医疗保险投保人数增加了 290 万人,医疗补助参保人数增加了 610 万人。政府和私营部门在医疗机构方面的支出,尤其是在新兴国家,正带动配备尖端技术的现代化外科中心的建设。这种扩张提高了先进外科手术的可近性和可负担性,增加了血管封闭设备的使用。此外,已开发国家和开发中国家都专注于改善手术效果和病人安全,这刺激了对高性能手术设备,尤其是血管封闭设备的需求。
仪器占大部分市场份额
血管封闭器械广泛应用于各种外科手术,包括一般外科、妇科、泌尿外科和心血管外科。它们能够持续止血并防止术中失血,使其成为许多复杂微创手术的必备器械。这些器械能够处理各种类型和大小的组织,并与各种外科手术相容,扩大了其应用范围。因此,手术数量的增加也推动了对血管封闭器械的需求,并带来了可观的市场份额。根据印度国家医学图书馆 2020 年发布的资料,印度人口为 88,273 人,每年共进行 4,642 例手术。其中,最常见的手术是白内障手术(22.8%)、剖腹产手术(3.8%)、骨折手术(3.27%)和疝气手术(2.86%)。此外,44.2% 的手术属于必要手术。
腹腔镜手术占据业界最大份额
先进的血管封闭技术显着提高了腹腔镜手术的精确度和安全性。这些技术使外科医生能够准确且快速地封闭动脉和组织束,从而减少失血和併发症风险。精准的封闭和切割控制可以减少温度向邻近组织的扩散,这对于腹腔镜手术中精细且有限的区域尤其重要。这种高精度水准推动了血管封闭装置在腹腔镜手术中的广泛应用。此外,腹腔镜设备和血管封闭技术的进步也使其更加普及。整合切割和封闭功能、人体工学设计和改进的能量传输系统等创新功能显着提高了血管封闭装置的有效性。
医院和专科诊所是主要的细分市场
慢性病发生率的上升是推动医院和专科诊所发展的关键因素。根据美国疾病管制与预防中心的数据,美国约有1.29亿人至少患有一种主要慢性病,例如心臟病、癌症、糖尿病、肥胖和高血压。此外,美国十大主要死因中有五种与可预防和可治疗的慢性病密切相关。过去20年,慢性病发生率稳定上升,预计这一趋势还会持续。糖尿病、高血压、癌症和呼吸系统疾病等慢性病需要持续的医疗照护、频繁的监测和专科治疗。这导致对能够有效管理这些疾病的医疗服务和设施的需求激增。专注于糖尿病护理、肿瘤科、心臟科和肺科的专科诊所正在扩张,以满足慢性病患者的需求,这反过来又增加了对血管封闭设备的需求。
北美引领市场,占据最大的血管密封装置市场份额
该报告还对所有主要区域市场进行了全面分析,包括北美(美国和加拿大);欧洲(德国、法国、英国、义大利、西班牙、俄罗斯等);亚太地区(中国、日本、印度、韩国、澳洲、印尼等);拉丁美洲(巴西、墨西哥等);以及中东和非洲。报告指出,北美是血管封闭装置最大的区域市场。
北美,尤其是美国,拥有世界上最先进的医疗体系之一。由平等机会研究基金会(FREOPP)发布的2021年世界医疗创新指数显示,美国在全球医疗体系中排名第六。分析发现,美国在科学进步方面处于全球领先地位,但其医疗体系在财务上难以为继。设备齐全的医院、专科手术设施和诊所的普及促进了血管封闭装置等创新医疗技术的使用。此外,该地区的医疗体系在尖端设备和技术方面投入巨资,从而能够提供高品质的外科护理。此外,公共和私营部门在医疗领域的高支出,也使得医疗技术和外科创新方面的投资成为可能。
The global vessel sealing devices market size reached USD 2.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.5 Billion by 2033, exhibiting a growth rate (CAGR) of 5.77% during 2025-2033. The market is propelled by rising prevalence of chronic diseases, technological advancements in surgical instruments, particularly in vessel sealing devices, and the increasing preference for minimally invasive surgeries.
Rising prevalence of chronic diseases
The rising frequency of chronic diseases like cancer, cardiovascular problems, and obesity is a major driver of the vessel sealing devices market growth. As these illnesses frequently require surgical procedures, there is an increased demand for sophisticated surgical equipment that can improve procedural efficacy and safety. As per Centers of Diseases Control and Prevention, an estimated 129 million people in the US have at least 1 major chronic disease including heart disease, cancer, diabetes, obesity, and hypertension. Besides, five of the top 10 leading causes of death in the US are, or are strongly associated with, preventable and treatable chronic diseases. Vessel sealing devices are especially important in procedures involving substantial tissue manipulation and hemostasis because they offer consistent sealing of blood vessels and tissue bundles, reducing intraoperative blood loss and postoperative problems. The growing burden of chronic diseases around the world, combined with the aging population, magnifies the need for surgical treatments, boosting the demand for effective vessel sealing solutions.
Increasing adoption of minimally invasive surgeries
Another key element creating a favorable vascular sealing devices market outlook is the transition to minimally invasive surgical (MIS) procedures. According to National Library of Medicine, in 2017, 9.8 million inpatient major operating room procedures were analyzed, of which 11.1% were MIS and 2.5% were robotic-assisted, compared with 9.6 million inpatient operating room procedures (11.2% MIS and 2.9% robotic-assisted) in 2018. Minimally invasive procedures, such as laparoscopic and robotic surgeries, have various advantages over traditional open surgeries, including less postoperative pain, shorter hospital stays, faster recovery times, and a lower chance of complications. Vessel sealing devices are essential for MIS procedures because they enable precise and successful hemostasis in limited surgical fields. The popularity of minimally invasive operations among patients and healthcare providers has led to increased demand for sophisticated vascular sealing technologies.
Rising healthcare expenditure
Increased healthcare spending and continued development of healthcare infrastructure worldwide are major drivers of the vessel sealing devices market. As per Centers for Medicare and Medicaid Services, U.S. health care spending grew 4.1% to reach $4.5 Trillion in 2022, faster than the increase of 3.2% in 2021. Besides, in 2022, the insured share of the population reached 92% (a historic high). Private health insurance enrollment increased by 2.9 million individuals and Medicaid enrollment increased by 6.1 million individuals. Government and private sector expenditures in healthcare facilities, particularly in emerging nations, are leading to the construction of modern surgery centers outfitted with cutting-edge technology. This expansion improves the accessibility and affordability of advanced surgical procedures, increasing the use of vessel sealing devices. Furthermore, the focus on improving surgical results and patient safety in both developed and developing nations encourages the demand for high-performance surgical equipment, particularly vascular sealing devices.
Instruments accounts for the majority of the market share
Vessel sealing instruments are utilized in many different surgical procedures, including general surgery, gynecology, urology, and cardiovascular surgery. Their ability to produce consistent hemostasis and prevent intraoperative blood loss makes them essential in many complex and minimally invasive operations. The adaptability of these devices in handling diverse tissue kinds and sizes, as well as their compatibility with various surgical procedures, broadens their use range. Hence, the increasing number of surgeries is escalating the demand for vessel sealing devices, resulting in a considerable market share. As per data published by National Library of Medicine in 2020, a total of 4642 surgeries were performed per year in India for a population of 88,273. Cataract (22.8%), caesareans (3.8%), surgeries for fractures (3.27%) and hernia (2.86%) were the most common surgeries. Moreover, 44.2% of surgeries belonged to essential surgeries.
Laparoscopic surgery holds the largest share of the industry
Advanced vascular sealing technologies considerably improve the precision and safety of laparoscopic surgery. These technologies enable surgeons to properly and swiftly seal blood arteries and tissue bundles, lowering blood loss and the risk of complications. The exact control over sealing and cutting decreases temperature diffusion to adjacent tissues, which is especially critical in the delicate and limited regions of laparoscopic surgery. This high level of precision drives the widespread adoption of vessel sealing devices in laparoscopic procedures. Besides, technological developments in both laparoscopic equipment and vascular sealing technologies have increased their popularity. Innovative features including integrated cutting and sealing capabilities, ergonomic designs, and improved energy delivery systems have considerably improved the effectiveness of vessel sealing devices.
Hospitals and specialty clinics represent the leading market segment
The rise in chronic diseases is a crucial factor driving the growth of hospitals and specialty clinics. As per Centers of Diseases Control and Prevention, an estimated 129 million people in the US have at least 1 major chronic disease such as heart disease, cancer, diabetes, obesity, hypertension. Moreover, five of the top 10 leading causes of death in the US are, or are strongly associated with, preventable and treatable chronic diseases. Over the past 2 decades prevalence has increased steadily, and this trend is expected to continue. Chronic conditions such as diabetes, hypertension, cancer, and respiratory diseases require ongoing medical attention, frequent monitoring, and specialized treatments. This has led to a surge in demand for healthcare services and facilities that can manage these conditions effectively. Specialty clinics focusing on diabetes care, oncology, cardiology, and pulmonology are expanding to meet the needs of patients with chronic diseases which in turn is escalating the vessel sealing devices demand.
North America leads the market, accounting for the largest vessel sealing devices market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest regional market for vessel sealing devices.
North America, especially he United States, has one of the most advanced healthcare systems in the world. The 2021 World Index on Healthcare Innovation, conducted by the Foundation for Research on Equal Opportunity (FREOPP), ranked the United States in 6th place among the world's healthcare systems. The analysis finds that the United States is a global leader in scientific advancement but that our healthcare system is fiscally unsustainable. The availability of well-equipped hospitals, specialist surgical facilities, and clinics promotes the use of innovative medical technologies, such as vascular sealing devices. Besides, the region's healthcare system invests heavily in cutting-edge equipment and technology, allowing for high-quality surgical care. Moreover, the high healthcare spending, led by both the public and private sectors, enables significant investment in medical technologies and surgical innovations.